Ibrutinib in Relapsed or Refractory Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia.
about
Ibrutinib in Relapsed or Refractory Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Ibrutinib in Relapsed or Refra ...... Chronic Lymphocytic Leukemia.
@ast
Ibrutinib in Relapsed or Refra ...... Chronic Lymphocytic Leukemia.
@en
type
label
Ibrutinib in Relapsed or Refra ...... Chronic Lymphocytic Leukemia.
@ast
Ibrutinib in Relapsed or Refra ...... Chronic Lymphocytic Leukemia.
@en
prefLabel
Ibrutinib in Relapsed or Refra ...... Chronic Lymphocytic Leukemia.
@ast
Ibrutinib in Relapsed or Refra ...... Chronic Lymphocytic Leukemia.
@en
P2860
P1476
Ibrutinib in Relapsed or Refra ...... Chronic Lymphocytic Leukemia.
@en
P2093
Derek Peterson
Joanna Schwartz
P2860
P304
P356
10.6004/JADPRO.2014.5.5.5
P577
2014-09-01T00:00:00Z